Work

A Phase 2 Trial of Cabozantinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Carcinoma in the First-Line Setting

Year: 2018

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2017.12.028

Authors: M.S. Brose, S. Shenoy, N. Bhat, A.K. Harlacker, R.K. Yurtal, Z.A. Posey, D.M. Torrente, C. Grande, C.M. Squillante, A.B. Troxel, M. Yarchoan

Institutions: University of Pennsylvania, Cooper University Hospital, New York University, Johns Hopkins University

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2789655974

FWCI: 0.601

Cites:

Cited by: 5

Related to: 10